KB:NYSEKB Financial Group Inc Analysis
Data as of 2026-04-12 - not real-time
$109.25
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
KB Financial Group trades at a forward P/E of 9.6, well below the industry average of 17.1, and offers a 2.3% dividend yield with a modest 23% payout ratio. The stock’s RSI of 63.6 suggests momentum is still on the upside side, while a bullish MACD histogram reinforces a short‑term positive bias. Volatility is elevated at 38% over the past 30 days, and beta hovers around 1.0, indicating market‑aligned risk. Technical levels show price sitting just below the resistance of 109.70 and well above the support of 94.72, giving an upside potential of roughly 15%. Recent earnings reported a 15.1% YoY profit increase driven by stronger non‑interest income, and short interest has collapsed to a negligible 0.09% of float. Despite negative operating cash flow, the firm maintains a low payout and a solid dividend, supporting sustainability. Overall, the combination of attractive valuation, dividend income, and earnings momentum creates a compelling case for investors.
The latest earnings call highlighted robust net profit growth and expanding fee income, reinforcing confidence in the bank’s core business model. Analysts note that the low short‑interest ratio reduces downside pressure, while the “Extreme Greed” sentiment in the fear‑greed index reflects strong market appetite. However, high volatility and a neutral trend suggest caution in the near term. The company’s exposure to South Korean macro‑economic conditions and regulatory environment introduces medium‑level geographic and regulatory risks, but its diversified international footprint mitigates extremes. Given the undervalued metrics and solid dividend, the stock appears positioned for medium‑ to long‑term appreciation, provided earnings momentum continues.
The latest earnings call highlighted robust net profit growth and expanding fee income, reinforcing confidence in the bank’s core business model. Analysts note that the low short‑interest ratio reduces downside pressure, while the “Extreme Greed” sentiment in the fear‑greed index reflects strong market appetite. However, high volatility and a neutral trend suggest caution in the near term. The company’s exposure to South Korean macro‑economic conditions and regulatory environment introduces medium‑level geographic and regulatory risks, but its diversified international footprint mitigates extremes. Given the undervalued metrics and solid dividend, the stock appears positioned for medium‑ to long‑term appreciation, provided earnings momentum continues.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish MACD but price near resistance
- Low short interest reducing downside
- High 30‑day volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to industry P/E
- Strong earnings growth and fee income
- Attractive dividend yield with low payout
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend and solid capital base
- Diversified geographic footprint
- Long‑term upside potential and earnings momentum
Key Metrics & Analysis
Financial Health
Revenue Growth31.80%
Profit Margin36.72%
P/E Ratio10.6
ROE9.68%
ROA0.75%
P/B Ratio4.2
Op. Cash Flow$-18923747540992
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI63.6
Support$94.72
Resistance$109.70
MA 20$101.80
MA 50$104.48
MA 200$89.09
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09
Valuation
Target Price$126.12
Upside/Downside15.44%
GradeUndervalued
TypeBlend
Dividend Yield2.30%
Risk Assessment
Beta1.00
Volatility38.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.